Premarket approval for AMS' (American Medical Systems) UroLume endoprosthesis:
This article was originally published in Clinica
Executive Summary
American Medical Systems has received US FDA approval to market its UroLume endoprosthesis, a braided wire mesh stent for treating detrusor-external sphincter dyssynergia (DESD), a urologic condition caused by spinal cord injuries. The UroLume is inserted in the urethra of these patients, who suffer a lack of co-ordination between the bladder and the urinary sphincter, leading to the bladder not being emptied completely. AMS of Minneapolis, Minnesota, had received approval for the UroLume in October 1996 for treating benign urethral stricture disease in men (see Clinica No 129, p 17).
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.